Oral Lichen Planus: A Narrative Review Navigating Etiologies, Clinical Manifestations, Diagnostics, and Therapeutic Approaches
- PMID: 39274493
- PMCID: PMC11396719
- DOI: 10.3390/jcm13175280
Oral Lichen Planus: A Narrative Review Navigating Etiologies, Clinical Manifestations, Diagnostics, and Therapeutic Approaches
Abstract
Background/Objectives: Oral Lichen Planus (OLP) is a common immune-mediated inflammatory disorder affecting the oral mucosa, impacting 0.5% to 2% of the global population, primarily middle-aged women. Immunological dysregulation is a key factor in OLP's pathogenesis, involving CD4+ T helper and CD8+ T cytotoxic cells. The World Health Organization (WHO) classifies OLP as a potentially malignant disorder, with a risk of oral squamous cell carcinoma (OSCC) developing in up to 2% of lesions. This narrative review aims to provide a comprehensive overview of the etiopathogenesis, clinical manifestations, diagnostic criteria, and therapeutic strategies for OLP, informing clinical practice and guiding future research. Methods: A review of the literature from the PubMed and Google Scholar databases was conducted up to December 2023, focusing on studies addressing the etiopathogenesis, diagnosis, clinical manifestations, and treatment of OLP. Results: OLP's pathogenesis is driven by immune dysregulation, with CD4+ and CD8+ cells playing crucial roles. Clinically, OLP presents as reticular, erosive, bullous, and plaque-like lesions. Diagnosis relies on clinical examination, histopathology, and direct immunofluorescence. Recent advancements in diagnostic markers and imaging techniques have improved detection and monitoring. Treatment primarily involves corticosteroids, but novel therapies such as curcumin, retinoids, and laser therapy are increasingly used for their effectiveness and reduced side effects. These treatments show promise in symptom reduction and recurrence prevention, although long-term data are needed. Conclusions: Regular screenings and biopsies are essential due to OLP's likelihood of malignant transformation. This study urges further investigation into long-term results, improved diagnostic techniques, and evidence-based treatment regimens.
Keywords: autoimmune; chronic inflammation; corticosteroids; oral lichen planus; oral lichenoid keratosis.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Evaluation of Potential Risk Factors that contribute to Malignant Transformation of Oral Lichen Planus: A Literature Review.J Contemp Dent Pract. 2016 Aug 1;17(8):692-701. doi: 10.5005/jp-journals-10024-1914. J Contemp Dent Pract. 2016. PMID: 27659090 Review.
-
Is Curcumin a Safe and Effective Therapeutic in the Treatment against Oral Lichen Planus?Curr Med Chem. 2023;30(15):1684-1688. doi: 10.2174/0929867330666221202150727. Curr Med Chem. 2023. PMID: 36476439 Review.
-
Updates on immunological mechanistic insights and targeting of the oral lichen planus microenvironment.Front Immunol. 2023 Jan 9;13:1023213. doi: 10.3389/fimmu.2022.1023213. eCollection 2022. Front Immunol. 2023. PMID: 36700192 Free PMC article. Review.
-
Oral lichen planus and lichenoid reactions: etiopathogenesis, diagnosis, management and malignant transformation.J Oral Sci. 2007 Jun;49(2):89-106. doi: 10.2334/josnusd.49.89. J Oral Sci. 2007. PMID: 17634721 Review.
-
Translational Research in Oral Lichen Planus: From Laboratory Discoveries to Clinical Applications.Cureus. 2024 Oct 14;16(10):e71462. doi: 10.7759/cureus.71462. eCollection 2024 Oct. Cureus. 2024. PMID: 39544604 Free PMC article. Review.
Cited by
-
Elucidating the role of lipid metabolism dysregulation in the transition from oral lichen planus to oral squamous cell carcinoma.J Transl Med. 2025 Apr 16;23(1):448. doi: 10.1186/s12967-025-06431-4. J Transl Med. 2025. PMID: 40241125 Free PMC article.
-
The association between skin allergy testing and oral squamous cell carcinoma in oral lichen planus: a retrospective cohort study.Arch Dermatol Res. 2025 Jan 9;317(1):207. doi: 10.1007/s00403-024-03681-y. Arch Dermatol Res. 2025. PMID: 39786644
-
Circulating Antibodies Against DSG1 and DSG3 in Patients with Oral Lichen Planus: A Scoping Review.Antibodies (Basel). 2025 Jun 18;14(2):51. doi: 10.3390/antib14020051. Antibodies (Basel). 2025. PMID: 40558105 Free PMC article. Review.
-
Impact of diabetes mellitus on patients affected by oral lichen planus: a retrospective study.Front Oral Health. 2025 Mar 31;6:1569212. doi: 10.3389/froh.2025.1569212. eCollection 2025. Front Oral Health. 2025. PMID: 40230621 Free PMC article.
-
Oral lichen planus treated with upadacitinib: A case series.JAAD Case Rep. 2025 Jul 1;63:125-127. doi: 10.1016/j.jdcr.2025.05.041. eCollection 2025 Sep. JAAD Case Rep. 2025. PMID: 40791760 Free PMC article. No abstract available.
References
-
- Wilson E. On lichen planus. J. Cutan. Med. Dis. Skin. 1869;3:117–132.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials